Cue Biopharma, Inc. (31) | Intellectual Property (4)
Browse by Subcategory
Recent Contracts
-
License Agreement, March 28, 2022
(Filed With SEC on March 30, 2022)
-
Third Amendment to License Agreement, dated October 22, 2021, by and between Cue Biopharma, Inc. and MIL 21E, LLC
(Filed With SEC on November 9, 2021)
-
First Amendment to the Amended and Restated License Agreement with Albert Einstein College of Medicine dated October 30, 2018
(Filed With SEC on March 9, 2021)
-
Second Amendment to License Agreement between the Registrant and MIL 21E, LLC
(Filed With SEC on June 26, 2020)